Literature DB >> 3016141

Cyclic adenosine nucleotides and growth hormone-releasing factor increase cytosolic growth hormone messenger RNA levels in cultured rat pituitary cells.

R N Clayton, L C Bailey, S D Abbot, A Detta, K Docherty.   

Abstract

The cellular mechanisms involved in GH biosynthesis have been investigated by the measurement of steady-state levels of cytosolic GH messenger RNA (mRNA) in primary cultures of rat pituitary cells using an RNA-complementary DNA (cDNA) hybridization assay. Growth hormone mRNA-cDNA hybridization increased in a linear manner with increasing cytosol concentration. Cellular GH mRNA levels rose by an average of 2.4-fold (range, 1.6-3.3; n = five experiments) after exposure to GH-releasing factor (GRF(1-40); 10 nmol/l) for 3 days. Treatment with GRF increased the release of GH into the culture medium, and depleted the cellular GH content by 40%. Total GH (in the medium plus cells) after GRF treatment increased by between 1.5- and 3.8-fold, a magnitude similar to the increase in GH mRNA levels. Treatment of cells with dibutyryl adenosine 3':5'-cyclic monophosphate (1 mmol/l) or forskolin (5 mumol/l) increased the levels of cytosolic GH mRNA by between 1.6- and 4.7-fold. These agents increased GH release into the medium, depleted cellular GH content and increased total GH in the system to the same extent as GRF (10 nmol/l). These data demonstrate that cyclic adenosine nucleotides may mediate the GRF induction of GH gene transcription. In addition, we have shown that increases in the levels of cellular GH mRNA are reflected by increased GH biosynthesis, suggesting that the regulation of hormone gene transcription is one cellular site for the control of hormone biosynthesis and, ultimately, hormone available for release.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016141     DOI: 10.1677/joe.0.1100051

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  3 in total

1.  Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells.

Authors:  Philip Zeitler; Gamini Siriwardana
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

2.  Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone.

Authors:  P Zeitler; G Siriwardana
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.925

Review 3.  Somatopause, weaknesses of the therapeutic approaches and the cautious optimism based on experimental ageing studies with soy isoflavones.

Authors:  Vladimir Z Ajdžanovic; Svetlana Trifunovic; Dragana Miljic; Branka Šošic-Jurjevic; Branko Filipovic; Marko Miler; Nataša Ristic; Milica Manojlovic-Stojanoski; Verica Miloševic
Journal:  EXCLI J       Date:  2018-03-21       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.